Trexquant Investment LP Syndax Pharmaceuticals Inc Transaction History

Trexquant Investment LP

  • $7.59 Billion
  • Q3 2024

A detailed history of Trexquant Investment LP transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Trexquant Investment LP holds 33,433 shares of SNDX stock, worth $468,062. This represents 0.01% of its overall portfolio holdings.

Number of Shares
33,433
Previous 93,906 64.4%
Holding current value
$468,062
Previous $1.93 Million 66.63%
% of portfolio
0.01%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$17.93 - $24.81 $1.08 Million - $1.5 Million
-60,473 Reduced 64.4%
33,433 $643,000
Q2 2024

Aug 13, 2024
BUY
$18.82 - $23.79 $363,489 - $459,480
19,314 Added 25.89%
93,906 $1.93 Million
Q1 2024

May 14, 2024
SELL
$19.71 - $24.57 $1.36 Million - $1.69 Million
-68,922 Reduced 48.02%
74,592 $1.78 Million
Q4 2023

Feb 09, 2024
BUY
$11.39 - $21.67 $1.63 Million - $3.11 Million
143,514 New
143,514 $3.1 Million
Q2 2023

Aug 11, 2023
BUY
$19.35 - $22.31 $419,469 - $483,636
21,678 Added 49.29%
65,657 $1.37 Million
Q1 2023

May 15, 2023
BUY
$20.66 - $28.98 $690,787 - $968,975
33,436 Added 317.14%
43,979 $928,000
Q4 2022

Feb 13, 2023
BUY
$20.64 - $26.24 $217,607 - $276,648
10,543 New
10,543 $268,000
Q1 2021

May 13, 2021
SELL
$19.28 - $24.59 $289,142 - $368,776
-14,997 Closed
0 $0
Q4 2020

Feb 11, 2021
SELL
$15.1 - $26.44 $201,011 - $351,969
-13,312 Reduced 47.02%
14,997 $334,000
Q3 2020

Nov 06, 2020
BUY
$13.39 - $17.48 $145,602 - $190,077
10,874 Added 62.37%
28,309 $418,000
Q2 2020

Aug 07, 2020
BUY
$8.94 - $20.98 $155,868 - $365,786
17,435 New
17,435 $258,000
Q1 2018

May 03, 2018
SELL
$8.71 - $14.82 $350,786 - $596,860
-40,274 Closed
0 $0
Q4 2017

Feb 09, 2018
BUY
$7.8 - $12.94 $225,599 - $374,263
28,923 Added 254.81%
40,274 $353,000
Q3 2017

Nov 09, 2017
BUY
$10.9 - $12.73 $123,725 - $144,498
11,351
11,351 $133,000

Others Institutions Holding SNDX

# of Institutions
231
Shares Held
90M
Call Options Held
1.01M
Put Options Held
692K
View Full List

About Syndax Pharmaceuticals Inc

SNDX Quotes by TradingView
  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $792M
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email